NORGES BANK - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 191 filers reported holding HERON THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.

Quarter-by-quarter ownership
NORGES BANK ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$697,500
-71.8%
279,000
-68.5%
0.00%
-100.0%
Q2 2022$2,475,070
-47.4%
887,122
+7.7%
0.00%0.0%
Q1 2022$4,709,402
-36.2%
823,322
+1.8%
0.00%
-50.0%
Q4 2021$7,386,000
-14.6%
808,960
+0.0%
0.00%0.0%
Q3 2021$8,647,000
-7.1%
808,865
+34.8%
0.00%0.0%
Q2 2021$9,310,000
-4.1%
599,865
+0.1%
0.00%0.0%
Q1 2021$9,712,000
-60.7%
599,119
-48.6%
0.00%
-66.7%
Q4 2020$24,691,000
+20.7%
1,166,605
-15.5%
0.01%
+20.0%
Q3 2020$20,456,000
-6.3%
1,380,271
-7.0%
0.01%
-16.7%
Q2 2020$21,836,000
+64.6%
1,484,415
+31.4%
0.01%
+20.0%
Q1 2020$13,266,000
-43.3%
1,129,998
+13.6%
0.01%
-28.6%
Q4 2019$23,384,000
+57.6%
995,080
+24.1%
0.01%
+40.0%
Q3 2019$14,833,000
+10.0%
801,791
+10.5%
0.01%
+25.0%
Q2 2019$13,488,000
-14.7%
725,523
+12.1%
0.00%
-20.0%
Q1 2019$15,816,000
+15.6%
647,140
+22.7%
0.01%0.0%
Q4 2018$13,679,000
-5.3%
527,351
+15.5%
0.01%0.0%
Q3 2018$14,446,000
+643.5%
456,439
+812.9%
0.01%
+400.0%
Q2 2018$1,943,000
+501.5%
50,000
+150.0%
0.00%
Q3 2017$323,000
+16.6%
20,0000.0%0.00%
Q2 2017$277,000
-7.7%
20,0000.0%0.00%
Q1 2017$300,00020,0000.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
TANG KEVIN C 760$1,900100.00%
Velan Capital Investment Management LP 2,500,000$6,250,0005.52%
GREAT POINT PARTNERS LLC 6,360,161$15,900,4033.12%
Cheyne Capital Management (UK) LLP 318,008$795,0201.39%
TANG CAPITAL MANAGEMENT LLC 3,755,934$9,389,8351.36%
Rubric Capital Management LP 11,750,000$29,375,0001.28%
Orchard Capital Management, LLC 1,391,080$3,477,7001.17%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 267,028$667,5700.81%
CM Management, LLC 250,000$6250.75%
Tejara Capital Ltd 493,619$1,234,0480.71%
View complete list of HERON THERAPEUTICS INC shareholders